No Data
Haohai Biotec (06826.HK) spent 0.199 million HKD to repurchase 7,200 shares on December 4.
On December 4, haohai biotec (06826.HK) announced that it spent 0.199 million Hong Kong dollars to repurchase 7200 shares on December 4.
haohai biotec (06826.HK) spent 0.363 million Hong Kong dollars to repurchase 0.013 million shares on December 3.
Grain Meeting December 3rd | haohai biotec (06826.HK) announced that on December 3, 2024, it spent 0.363 million Hong Kong dollars to repurchase 0.013 million shares at a repurchase price of HK$27.85-28 per share.
haohai biotec (06826.HK) has repurchased a total of 0.138 million shares of A-shares as of November 30, 2024.
Gelonghui, December 2nd丨haohai biotec (06826.HK) announced that as of November 30, 2024, the company has repurchased a total of 138,150 A-shares through centralized bidding trade, accounting for 0.06% of the company's total share capital of 234,190,295 shares. The highest fill price was 63.58 yuan per share, the lowest fill price was 62.73 yuan per share, and the total transaction amount was 8,725,748.33 yuan (excluding stamp duty, transaction commission, and other transaction costs).
Haohai Biotec (06826.HK) spent 0.2071 million Hong Kong dollars to repurchase 7500 shares on December 2nd.
On December 2, Gelonghui reported that haohai biotec (06826.HK) announced the repurchase of 7,500 shares at a cost of 0.2071 million Hong Kong dollars on December 2, 2024, with a repurchase price of 27.6-27.65 Hong Kong dollars per share.
Haohai Biotec (06826) plans to use no more than 0.4 billion yuan of temporarily idle raised funds for cash management.
Haohai Biotec (06826) announced that the company plans to use no more than 0.4 billion yuan (including this amount) of temporarily idle...
Shanghai Haohai Biological Technology (688366.SH): plans to use no more than 0.4 billion yuan of temporarily idle raised funds for cash management.
On November 29, Gelonghui reported that shanghai haohai biological technology (688366.SH) announced that the company plans to use temporarily idle raised funds for cash management, with a maximum amount not exceeding 400 million yuan, provided that it does not affect the normal progress of the company's fundraising investment plan. The funds will be used to purchase high-security, good liquidity, and guaranteed principal investment products (including but not limited to agreed deposits, notice deposits, term deposits, large certificates of deposit, income certificates, etc.), with a duration not exceeding the construction period of the fundraising projects and valid within 12 months from the date of approval by the board of directors. Within the aforementioned limit and timeframe, the company can recycle.
Investors Interested In Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Earnings
No Data
